Laura Deming
Venture Capitalist | Early-Stage Startup Investing
About
Laura Deming is a leading venture capitalist focused on funding transformative life sciences and longevity startups. She started investing at age 8 and launched her first fund, The Longevity Fund, at just 17 years old.
Deming has since backed groundbreaking companies like Unity Biotechnology that aim to extend the human healthspan. As a partner at acclaimed VC firm a16z, she leverages deep scientific expertise to identify the most promising life extension technologies.
Deming's keynotes share the investment theses and founder stories behind the companies extending the frontiers of human longevity.
Is this you?
Claim this profile to edit your bio, add talks, and get verified.
Know a talk we're missing?
Get in Touch
Save for Later
Similar Speakers
Speakers with related expertise
Tony Wyss-Coray
Stanford Professor | Groundbreaking Alzheimer's Research
Cynthia Kenyon
Molecular Biologist | Longevity Research Pioneer
Karissa Sanbonmatsu
Molecular Biologist | Discovering the Epigenetic Code of Life
Jim Hudspeth
Neuroscientist | The Surprising Science of Hearing